CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 2.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395,847 | -15.9% | 43,740 | 0.0% | 0.00% | – |
| Q2 2023 | $470,642 | +40.7% | 43,740 | +33.8% | 0.00% | – |
| Q1 2023 | $334,521 | +12.4% | 32,700 | +16.0% | 0.00% | – |
| Q4 2022 | $297,510 | -13.0% | 28,200 | +5.6% | 0.00% | – |
| Q3 2022 | $342,000 | +9.6% | 26,700 | +9.9% | 0.00% | – |
| Q2 2022 | $312,000 | +110.8% | 24,300 | +72.3% | 0.00% | – |
| Q1 2022 | $148,000 | -39.6% | 14,100 | -11.3% | 0.00% | – |
| Q4 2021 | $245,000 | -21.2% | 15,900 | +15.2% | 0.00% | – |
| Q3 2021 | $311,000 | -12.4% | 13,800 | 0.0% | 0.00% | – |
| Q2 2021 | $355,000 | – | 13,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $78,241,782 | 20.33% |
| CHI Advisors LLC | 3,349,460 | $34,264,977 | 9.10% |
| Nextech Invest Ltd. | 1,221,145 | $12,492,313 | 5.21% |
| BVF INC/IL | 3,196,701 | $32,702,251 | 1.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 265,032 | $2,711,277 | 1.12% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $5,115,000 | 0.76% |
| Atom Investors LP | 120,109 | $1,228,715 | 0.67% |
| Boxer Capital, LLC | 1,074,082 | $10,988 | 0.54% |
| SVB FINANCIAL GROUP | 20,274 | $207,403 | 0.40% |
| Parkman Healthcare Partners LLC | 169,886 | $1,737,934 | 0.38% |